Loading clinical trials...
Loading clinical trials...
ML-004-003 is a multi-center, open-label extension study that will enroll approximately 120 adolescent and adult subjects with ASD that have completed study ML-004-002. The primary objective of the st...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
MapLight Therapeutics
NCT06066983 · Autism Spectrum Disorder, Anxiety Disorders
NCT07439276 · Neurodevelopmental Disorders, Autism Spectrum Disorder, and more
NCT06158581 · Autism Spectrum Disorder
NCT04631042 · Typical Development, Obsessive Compulsive Disorder, and more
NCT07421830 · Autism Spectrum Disorder (ASD)
Harmonex Neuroscience Research
Dothan, Alabama
Southwest Autism Research and Resource Center
Phoenix, Arizona
Cortica Healthcare
Glendale, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions